Essential Role of Bromodomain Proteins in Renal Cell Carcinoma (Review)

Overview

Journal Mol Med Rep

Specialty Molecular Biology

Date 2023 Jun 9

PMID 37293842

Authors

Qianghai Wen

Haicheng Liu

Kecheng Lou

Xing Zhang

Wei Chao

Jianhui Xin

Jiaxiang Gong

Junrong Zou

Xiaofeng Zou

Affiliations

Soon will be listed here.

Abstract

Histone alterations are a hallmark of kidney cancer. Histone acetylation modification mediated by bromodomain proteins (BRD) has been indicated to be related to a variety of cancer types and several targeted inhibitors have been proven to be promising modalities for cancer adjuvant therapy. As renal cell carcinoma (RCC) is not sensitive to radiotherapy or chemotherapy, the exploration of effective adjuvant therapies remains an important research direction for advanced RCC. At present, studies on bromodomain family proteins in RCC are limited and the roles of bromodomain family proteins in RCC have remained to be fully elucidated. The present review discussed the role of bromodomain family proteins in RCC, aiming to explore possible potential therapeutic targets of BRD‑related drugs in this type of cancer.

Citing Articles

Network modeling links kidney developmental programs and the cancer type-specificity of VHL mutations.

Dong X, Zhang D, Zhang X, Liu Y, Liu Y NPJ Syst Biol Appl. 2024; 10(1):114.

PMID: 39362887 PMC: 11449910. DOI: 10.1038/s41540-024-00445-2.

The role of RNA-modifying proteins in renal cell carcinoma.

Alhammadi M, Bajbouj K, Talaat I, Hamoudi R Cell Death Dis. 2024; 15(3):227.

PMID: 38503745 PMC: 10951318. DOI: 10.1038/s41419-024-06479-y.

Noval advance of histone modification in inflammatory skin diseases and related treatment methods.

Zhang L, Chai R, Tai Z, Miao F, Shi X, Chen Z Front Immunol. 2024; 14:1286776.

PMID: 38235133 PMC: 10792063. DOI: 10.3389/fimmu.2023.1286776.

References

Wang Z, Li K, Chen W, Wang X, Huang Y, Wang W . Modulation of SRSF2 expression reverses the exhaustion of TILs via the epigenetic regulation of immune checkpoint molecules. Cell Mol Life Sci. 2019; 77(17):3441-3452. PMC: 7426320. DOI: 10.1007/s00018-019-03362-4. View

Shanmugasundaram K, Nayak B, Friedrichs W, Kaushik D, Rodriguez R, Block K . NOX4 functions as a mitochondrial energetic sensor coupling cancer metabolic reprogramming to drug resistance. Nat Commun. 2017; 8(1):997. PMC: 5648812. DOI: 10.1038/s41467-017-01106-1. View

Jin W, Miao Q, Wang M, Zhang Y, Ma Y, Huang Y . A rare case of adrenal gland abscess due to anaerobes detected by metagenomic next-generation sequencing. Ann Transl Med. 2020; 8(5):247. PMC: 7154389. DOI: 10.21037/atm.2020.01.123. View

Xu Y, Wu G, Zhang J, Li J, Ruan N, Zhang J . TRIM33 Overexpression Inhibits the Progression of Clear Cell Renal Cell Carcinoma In Vivo and In Vitro. Biomed Res Int. 2020; 2020:8409239. PMC: 7468622. DOI: 10.1155/2020/8409239. View

Brownlee P, Chambers A, Oliver A, Downs J . Cancer and the bromodomains of BAF180. Biochem Soc Trans. 2012; 40(2):364-9. DOI: 10.1042/BST20110754. View

Lee S, Kang J, Ha J, Lee J, Oh S, Choi H . Transglutaminase 2-Mediated p53 Depletion Promotes Angiogenesis by Increasing HIF-1α-p300 Binding in Renal Cell Carcinoma. Int J Mol Sci. 2020; 21(14). PMC: 7404067. DOI: 10.3390/ijms21145042. View

Feng L, Wang G, Chen Y, He G, Liu B, Liu J . Dual-target inhibitors of bromodomain and extra-terminal proteins in cancer: A review from medicinal chemistry perspectives. Med Res Rev. 2021; 42(2):710-743. PMC: 8837683. DOI: 10.1002/med.21859. View

Delmore J, Issa G, Lemieux M, Rahl P, Shi J, Jacobs H . BET bromodomain inhibition as a therapeutic strategy to target c-Myc. Cell. 2011; 146(6):904-17. PMC: 3187920. DOI: 10.1016/j.cell.2011.08.017. View

Kuo M, Brownell J, Sobel R, Ranalli T, Cook R, Edmondson D . Transcription-linked acetylation by Gcn5p of histones H3 and H4 at specific lysines. Nature. 1996; 383(6597):269-72. DOI: 10.1038/383269a0. View

10.

Mashtalir N, DAvino A, Michel B, Luo J, Pan J, Otto J . Modular Organization and Assembly of SWI/SNF Family Chromatin Remodeling Complexes. Cell. 2018; 175(5):1272-1288.e20. PMC: 6791824. DOI: 10.1016/j.cell.2018.09.032. View

11.

Izzo A, Schneider R . The role of linker histone H1 modifications in the regulation of gene expression and chromatin dynamics. Biochim Biophys Acta. 2015; 1859(3):486-95. DOI: 10.1016/j.bbagrm.2015.09.003. View

12.

Latif A, Newcombe A, Li S, Gilroy K, Robertson N, Lei X . BRD4-mediated repression of p53 is a target for combination therapy in AML. Nat Commun. 2021; 12(1):241. PMC: 7801601. DOI: 10.1038/s41467-020-20378-8. View

13.

Zhu H, Mao J, Wang Y, Gu D, Pan X, Shan Y . Dual inhibition of BRD4 and PI3K-AKT by SF2523 suppresses human renal cell carcinoma cell growth. Oncotarget. 2017; 8(58):98471-98481. PMC: 5716743. DOI: 10.18632/oncotarget.21432. View

14.

Ji S, Su X, Zhang H, Han Z, Zhao Y, Liu Q . MicroRNA-372 functions as a tumor suppressor in cell invasion, migration and epithelial-mesenchymal transition by targeting in renal cell carcinoma. Oncol Lett. 2019; 17(2):2400-2408. PMC: 6350190. DOI: 10.3892/ol.2018.9871. View

15.

Pawlus M, Wang L, Hu C . STAT3 and HIF1α cooperatively activate HIF1 target genes in MDA-MB-231 and RCC4 cells. Oncogene. 2013; 33(13):1670-9. PMC: 3868635. DOI: 10.1038/onc.2013.115. View

16.

Jung J, Lee H, Cho I, Chung D, Yoon S, Yang Y . STAT3 is a potential modulator of HIF-1-mediated VEGF expression in human renal carcinoma cells. FASEB J. 2005; 19(10):1296-8. DOI: 10.1096/fj.04-3099fje. View

17.

Porter E, Dhiman A, Chowdhury B, Carter B, Lin H, Stewart J . PBRM1 Regulates Stress Response in Epithelial Cells. iScience. 2019; 15:196-210. PMC: 6514269. DOI: 10.1016/j.isci.2019.04.027. View

18.

Cocco E, Leo M, Canzonetta C, Di Vito S, Mai A, Rotili D . KAT3B-p300 and H3AcK18/H3AcK14 levels are prognostic markers for kidney ccRCC tumor aggressiveness and target of KAT inhibitor CPTH2. Clin Epigenetics. 2018; 10:44. PMC: 5885315. DOI: 10.1186/s13148-018-0473-4. View

19.

Gu Y, Cohn S, Christie A, McKenzie T, Wolff N, Do Q . Modeling Renal Cell Carcinoma in Mice: and Inactivation Drive Tumor Grade. Cancer Discov. 2017; 7(8):900-917. PMC: 5540776. DOI: 10.1158/2159-8290.CD-17-0292. View

20.

Zahid H, Olson N, Pomerantz W . Opportunity knocks for uncovering the new function of an understudied nucleosome remodeling complex member, the bromodomain PHD finger transcription factor, BPTF. Curr Opin Chem Biol. 2021; 63:57-67. PMC: 8384639. DOI: 10.1016/j.cbpa.2021.02.003. View